About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

US Doctors Use Real-time System to Plant 'seeds' Against Prostate Cancer

by VR Sreeraman on September 22, 2007 at 2:38 PM
Font : A-A+

US Doctors Use Real-time System to Plant 'seeds' Against Prostate Cancer

A multidisciplinary team of medical practitioners in the US has started using a real-time system to implant radiation-emitting seeds in patients with prostate cancer.

Doctors at the Kimmel Cancer Center at Jeferson and Thomas Jefferson University Hospital in Philadelphia have revealed that the new mechanism is being used for imaging and planning purposes only.

Advertisement

The real-time system to implant radiation-emitting seeds has been developed by Nucletron, a technology company based in The Netherlands.

According to cancer experts, the system may help with the actual placement of the seeds.

The team—involving urologists, surgeons, radiation oncologists, and radiation physicists—hopes that the new federal Food and Drug Administration-approved technology will make an already good system even better, adding scientific precision to a treatment that currently relies mainly on physician experience and skill.
Advertisement

"The device is a step above the traditional technique because it makes use of a more sophisticated approach that allows for a coordinated, real-time imaging-based implantation of seeds," Dr. Richard Valicenti, associate professor of radiation oncology at Jefferson Medical College of Thomas Jefferson University, said about the Nucletron device.

Patients have two options for treatment for localized, low-risk prostate cancer confined to the prostate—surgery or radiation therapy.

In brachytherapy, tiny pellets called seeds of the size of a grain of rice blanket the prostate, giving off radiation that travels only a few millimetres to kill nearby cancer cells. The seeds are carefully placed inside the cancerous tissue, and positioned to efficiently attack the cancer.

This therapy has been proven to be very effective and safe, providing a good alternative to surgical removal of the prostate, while reducing the risk of certain long-term side effects, such as impotence. The seed radioactivity decays with time, while the seeds stay within the treatment area.

"This new approach is automated, so what normally takes us many steps to do we can do very quickly," says Dr. Valicenti, noting that brachytherapy is highly operator-dependent.

"For example, putting in the rectal ultrasound probe has to be done slowly by hand. Now, the device does it and takes measurements of the size and location automatically of the target gland," he adds.

The device thus gathers the imaging information, such as the dimensions of the patient's prostate, and downloads it into a computer system, where it is rapidly processed.

Based on the data collected, the medical practitioners specify the parameters of treating the cancer—such as how much dose to give the prostate, how much extra dose to give to the area of the tumour and the positions in which to give the radiation.

Dr. Valicenti says that all this is done in less time than previously possible with standard techniques.

"Up until recently, we would produce a plan in the outpatient setting that we hoped to recapitulate in the operating room. But there was always the concern that what we saw initially might not match the situation later," says Dr. Adam Dicker, professor of radiation oncology at Jefferson Medical College.

He says that the patient's position and the location and condition of his prostate can affect planning.

Since the new system enables real-time planning in the operating room, he says: "If an area is under-dosed, you can find out right away and make corrections."

The Nucletron device provides a multidimensional view of the prostate and the "ability to process and accumulate more precise information, constantly updating and readjusting the treatment plan."

Source: ANI
SRM /J
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Memory Loss - Can it be Recovered?
International Day of Persons with Disabilities 2021 - Fighting for Rights in the Post-COVID Era
Effect of Blood Group Type on COVID-19 Risk and Severity
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Prostate Cancer Cancer and Homeopathy Trans-Urethral Resection of the Prostate Prostate Cancer Facts Cancer Facts Cancer Eradicate Quackery, Save Lives Prostate Cancer: Treatment Options Prostate Specific Antigen [PSA] Different Medical Specialists and their Area of Medical Expertise 

Recommended Reading
Prostate Cancer Drug may also Help Detect the Disease Early
Finasteride, a generic prostate cancer drug, may also shrink prostate tumours, making the prostate ....
Different Medical Specialists and their Area of Medical Expertise
A medical specialist is a recognized expert in his field and is usually accredited by a medical boa...
Eradicate Quackery, Save Lives
Quackery means promotion of a medical cure which is otherwise scientifically unproven and baseless....
Prostate Cancer
This cancer affects men over the age of 50 years and screening with rectal examination and PSA can h...
Prostate Cancer: Treatment Options
Treatment options of prostate cancer includes waiting, surgery, radiation, hormone therapy, chemothe...
Prostate Specific Antigen [PSA]
PSA blood test is specific to prostate gland but not necessarily a cancer specific test but is commo...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use